[go: up one dir, main page]

EE05381B1 - MeetodÁ2-(asendatudÁfenl)-2-hdroksetlkarbamaatideÁvalmistamiseks,ÁselleksÁvajalikudÁvahehendidÁningÁsaadudÁkarbamaatideÁpolmorfsedÁvormid - Google Patents

MeetodÁ2-(asendatudÁfenl)-2-hdroksetlkarbamaatideÁvalmistamiseks,ÁselleksÁvajalikudÁvahehendidÁningÁsaadudÁkarbamaatideÁpolmorfsedÁvormid

Info

Publication number
EE05381B1
EE05381B1 EEP200400098A EEP200400098A EE05381B1 EE 05381 B1 EE05381 B1 EE 05381B1 EE P200400098 A EEP200400098 A EE P200400098A EE P200400098 A EEP200400098 A EE P200400098A EE 05381 B1 EE05381 B1 EE 05381B1
Authority
EE
Estonia
Prior art keywords
diacarbamates
morpho
carbamates
formations
phenyl
Prior art date
Application number
EEP200400098A
Other languages
English (en)
Inventor
Max�Rey�(surnud)
Thomas�Otten
Daniel�Korey
Original Assignee
Ortho-McNeil�Pharmaceutical,�Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho-McNeil�Pharmaceutical,�Inc. filed Critical Ortho-McNeil�Pharmaceutical,�Inc.
Publication of EE200400098A publication Critical patent/EE200400098A/et
Publication of EE05381B1 publication Critical patent/EE05381B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1786—Unsaturated ethers containing hydroxy or O-metal groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP200400098A 2001-12-21 2002-12-19 MeetodÁ2-(asendatudÁfenl)-2-hdroksetlkarbamaatideÁvalmistamiseks,ÁselleksÁvajalikudÁvahehendidÁningÁsaadudÁkarbamaatideÁpolmorfsedÁvormid EE05381B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01205097 2001-12-21
US41808402P 2002-10-11 2002-10-11
PCT/EP2002/014843 WO2003053916A1 (en) 2001-12-21 2002-12-19 Process for preparing 2-(substituted phenyl) - 2 - hydroxy-ethyl carbamates

Publications (2)

Publication Number Publication Date
EE200400098A EE200400098A (et) 2004-10-15
EE05381B1 true EE05381B1 (et) 2011-02-15

Family

ID=26077052

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200400098A EE05381B1 (et) 2001-12-21 2002-12-19 MeetodÁ2-(asendatudÁfenl)-2-hdroksetlkarbamaatideÁvalmistamiseks,ÁselleksÁvajalikudÁvahehendidÁningÁsaadudÁkarbamaatideÁpolmorfsedÁvormid

Country Status (22)

Country Link
EP (2) EP1461309A1 (et)
JP (1) JP4610899B2 (et)
KR (1) KR20090097966A (et)
CN (1) CN100457723C (et)
AR (1) AR038055A1 (et)
AU (3) AU2002358806B2 (et)
BG (1) BG108759A (et)
BR (1) BR0215237A (et)
CA (2) CA2471485C (et)
CZ (1) CZ2004718A3 (et)
EE (1) EE05381B1 (et)
HR (1) HRP20040557A2 (et)
HU (1) HUP0402491A2 (et)
IL (3) IL162405A0 (et)
MX (1) MXPA04006135A (et)
MY (1) MY142415A (et)
NO (1) NO20043105L (et)
NZ (1) NZ533592A (et)
PL (1) PL370977A1 (et)
SK (1) SK2572004A3 (et)
TW (1) TWI333944B (et)
WO (1) WO2003053916A1 (et)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767843B2 (en) * 2006-03-02 2010-08-03 Apotex Pharmachem Inc. Process for the preparation of phenylcarbamates
KR20090076958A (ko) * 2006-10-06 2009-07-13 얀센 파마슈티카 엔.브이. 신규 (ｓ)-(＋)-2-(2-클로로페닐)-2-하이드록시-에틸 카바메이트 결정
US20090105498A1 (en) * 2007-10-18 2009-04-23 Porstmann Frank Improved process for preparing 2-(substituted phenyol)-2-hydroxy-ethyl-carbamates
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
EP2797881B1 (en) * 2011-12-27 2018-11-14 Bio-Pharm Solutions Co., Ltd. Phenyl alkyl carbamate derivative compound and pharmaceutical composition containing the same
KR102421006B1 (ko) * 2016-05-19 2022-07-14 에스케이바이오팜 주식회사 두통의 예방학적 치료를 위한 카바메이트 화합물의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5671M (et) * 1965-04-23 1968-01-02
US5504108A (en) * 1990-01-12 1996-04-02 The Ohio State University Research Foundation Optically pure 4-aryl-2-hydroxytetronic acids
JP3010497B2 (ja) * 1990-05-31 2000-02-21 チッソ株式会社 光学活性α―ヒドロキシエステル類の製造方法
US5831133A (en) 1994-10-19 1998-11-03 Firmenich Sa Process for the preparation of alcohols
US5698588A (en) 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
US6642395B1 (en) * 1999-11-29 2003-11-04 Mitsubishi Rayon Co., Ltd. Acetalsulfonate derivative, process for producing the same, and process for producing styrene oxide derivative

Also Published As

Publication number Publication date
HUP0402491A2 (hu) 2005-04-28
EP2248799A1 (en) 2010-11-10
CN1620425A (zh) 2005-05-25
TWI333944B (en) 2010-12-01
TW200405809A (en) 2004-04-16
NZ533592A (en) 2006-05-26
IL162405A0 (en) 2005-11-20
KR20090097966A (ko) 2009-09-16
NO20043105L (no) 2004-07-20
AU2002358806A1 (en) 2003-07-09
AU2011201613A1 (en) 2011-04-28
AR038055A1 (es) 2004-12-22
EP1461309A1 (en) 2004-09-29
MXPA04006135A (es) 2004-11-01
CA2471485A1 (en) 2003-07-03
HRP20040557A2 (en) 2005-04-30
WO2003053916A1 (en) 2003-07-03
EE200400098A (et) 2004-10-15
CA2681964A1 (en) 2003-07-03
AU2009212987A1 (en) 2009-10-01
CZ2004718A3 (cs) 2004-12-15
EP2248799B1 (en) 2015-05-20
CA2471485C (en) 2011-05-24
SK2572004A3 (sk) 2005-02-04
BG108759A (bg) 2005-03-31
AU2002358806B2 (en) 2009-09-10
CN100457723C (zh) 2009-02-04
IL162405A (en) 2011-08-31
JP2005513126A (ja) 2005-05-12
BR0215237A (pt) 2004-11-16
JP4610899B2 (ja) 2011-01-12
PL370977A1 (en) 2005-06-13
MY142415A (en) 2010-11-30
IL213960A0 (en) 2011-08-31

Similar Documents

Publication Publication Date Title
IS2940B (is) Mótefni gegn CD40
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
DK1380121T3 (da) Fremgangsmåde til fremstilling af oxazolidinoner
EE200300400A (et) Pürimidiiniühendid, nende valmistamismeetod ning kasutamine
DK1411926T3 (da) Integrininhibitorer til behandling af öjensygdomme
NO20033433L (no) Fremgangsmåte for fremstilling av 2-(2-pyridylmetyl)sulfinyl- 1H-benzimidasol
EE200100383A (et) L-fenüülefriinvesinikkloriidi valmistamise meetod
FI20011541A0 (fi) Menetelmä massan valmistamiseksi
NO20033803D0 (no) Karbamat for behandling av bevegelseslidelser
DE60203537D1 (de) 5ht1-rezeptoragonist enthaltendes arzneimittel
ATE392418T1 (de) Substituierte fluoralkoxyphenylsulfonylharnstoffe
FI20011168L (fi) Menetelmä infektion laadun määrittämiseksi
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
IL213960A0 (en) 2-(substituted phenyl)-2-hydroxyl -ethyl carbamates
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
DK1373232T3 (da) Fremgangsmåde til fremstilling af N-substituerede 2,6-dialkylmorpholiner
DE60236534D1 (de) Verbesserte herbizidzusammensetzung
PT1281707E (pt) Processo para a preparacao de isobenzofuranos 5-substituidos
FI20020163A0 (fi) Menetelmä selluloosakarbamaatin valmistamiseksi
IL182445A0 (en) Process for the preparation of n-(3,5-dichloropyrid-4-yl)-4difluoromethoxy-8-methanesulfona mido-dibenzo[b,d]furan-1-caboxamide
DK1493442T3 (da) Reboxetin til behandling af perifer neuropati
DK1392711T3 (da) Fremgangsmåde til fremstilling af xylose
FI20012552A0 (fi) Metallikarbonaatin valmistusmenetelmä
DE50115802D1 (de) Dafür
PT1490363E (pt) Processos de preparacao da 2-(7-cloro-1,8-naftiridina-2-il)-3-(5-metil-2-oxo-hexil)-1-isoindolinona

Legal Events

Date Code Title Description
MM4A Lapsed by not paying the annual fees

Effective date: 20111219